The Next Generation of GLP-1 Focused Hypoglycemic Therapeutics Patent
The modern diabetes market is no longer just about lowering blood glucose. It is about long-term metabolic control without escalating cost, complexity, or physiological trade-offs. Type 2 diabetes management has…
